Načítá se...
Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates
COVID-19 vaccines emerging from different platforms differ in efficacy, duration of protection, and side effects. To maximize the benefits of vaccination, we explored the utility of employing a heterologous prime-boost strategy in which different combinations of the four types of leading COVID-19 va...
Uloženo v:
| Vydáno v: | Emerg Microbes Infect |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8009122/ https://ncbi.nlm.nih.gov/pubmed/33691606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/22221751.2021.1902245 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|